Mode
Text Size
Log in / Sign up
N/A N=35 Randomized Health Services Research

Optimizing Active Surveillance in Low-Risk Prostate Cancer: a Pilot Study

Prostate Cancer

Enrolled (actual)
35
Serious AEs
0.0%
Results posted
Mar 2026
Primary outcome: Primary: Feasibility - Recruitment — 39 Participants

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
web-based tool (MAP- Management of Active surveillance in Prostate Cancer) (Behavioral); MUSIC website (Behavioral)
Age
Adult, Older Adult · 55+ yrs
Sex
Male
Sponsor
University of Michigan Rogel Cancer Center
Primary completion
Mar 2024

Outcome Measures

OutcomeResultp-value
PRIMARY
Feasibility - Recruitment
39
PRIMARY
Feasibility - Uptake
30
PRIMARY
Acceptability - Mean Satisfaction Scores
3.53; 3.70; 3.30; 2.80; 3.40; 4.40

Summary

This is a pilot evaluation of a patient-centered intervention that enables providers to support men on active surveillance to maximize adherence. Conducted in urology practices, this pilot will measure key patient-reported, provider-reported, and implementation outcomes. Successful completion of this work will inform a subsequent multi-center effectiveness-implementation hybrid design trial and ultimately will improve low-risk cancer management by effectively engaging Primary Care Physicians (PCPs) in care delivery.

Eligibility Criteria

Patient Inclusion Criteria:

  • 55 years old or older
  • Men diagnosed with low-risk prostate cancer currently on active surveillance
  • Men who identify having a primary care provider
  • Access and ability to use the Internet

Patient Exclusion Criteria:

  • Men who are unable to read and/or speak English
  • Men with impaired decision-making capacity (such as with a diagnosis of dementia or memory loss)

PCP Inclusion Criteria:

  • Identified by patient on baseline survey as their PCP

Urologist and Clinic Staff Inclusion Criteria:

  • Clinicians or staff at a participating urology clinic, including but not limited to MDs, APPs, and nurses
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT05764005). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search